• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    More On OXI.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    OXIS International, Inc. (OXI.PA)

    -Paris
    0.02 Up 0.01(100.00%) Jul 31, 10:30AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    OXIS International, Inc.
    4830 West Kennedy Boulevard
    Suite 600
    Tampa, FL 33609
    United States - Map
    Phone: 800-304-9888
    Website: http://oxis.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:2

    Business Summary 

    Oxis International, Inc., through its subsidiary, Oxis Biotech, Inc., discovers, develops, and commercializes therapeutics from its proprietary product platform in various disease areas in the United States. The company is developing drugs for the treatment of cancer and other unmet medical needs. Its lead drug candidates include OXS-2175, a small molecule therapeutic candidate for the treatment of triple-negative breast cancer; and OXS-4235, a small molecule therapeutic candidate to treat multiple myeloma and associated osteolytic lesions. The company was formerly known as DDI Pharmaceuticals, Inc. and changed its name to Oxis International, Inc. in 1994. Oxis International, Inc. was founded in 1965 and is based in Tampa, Florida.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on OXIS International, Inc.

    Key Executives 
     PayExercised
    Mr. Anthony J. Cataldo , 64
    Chairman and Chief Exec. Officer
    154.00K0.00
    Mr. Steven W. Weldon MBA, CPA, 39
    Pres, Chief Financial Officer, Chief Accounting Officer and Director
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.